The JSE was on track for its second day of gains on Monday as developments in the search for a coronavirus treatment boosted risk appetite. 

Global equities rallied on news that the US Food and Drug Administration authorised the use of blood plasma as a treatment for Covid-19 patients. ..

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now